Literature DB >> 31372889

Assessment of the aerosol distribution pattern of a single-port device for intraperitoneal administration of therapeutic substances.

Rafael Seitenfus1,2, Antonio Nocchi Kalil3, Eduardo Dipp de Barros3, Claudio Galeano Zettler4, Gabriel Oliveira Dos Santos4, Olivier Glehen5, Carlos Humberto Cereser Junior3, Paulo Roberto Walter Ferreira6,7.   

Abstract

BACKGROUND: In the last 20 years, intraperitoneal chemotherapy (IPC) has been explored as a modality for the management of peritoneal metastases of gynecologic, gastrointestinal, and primary peritoneal tumors. Direct delivery of chemotherapeutic agents to the peritoneal cavity space has proved superior to systemic chemotherapy when evaluating characteristics such as drug concentration reached in the peritoneal space, penetration into peritoneal metastases, and chemotherapy-related toxicity. Traditionally, IPC is delivered by peritoneal lavage with a liquid solution. This form of delivery has limitations, including inhomogeneous intraperitoneal distribution and limited ability to penetrate tissues and metastatic nodules. An alternative mode of delivery is so-called pressurized intraperitoneal aerosol chemotherapy (PIPAC). Within this context, the present study sought to identify the pattern of spatial distribution of therapeutic solutions aerosolized into the peritoneal space using a single-port PIPAC device and ascertain whether the aerosolized method is superior to the traditional (liquid) mode of IPC delivery.
METHODS: Analysis of the rate of intra-abdominal staining with aerosolized 2% silver nitrate in five porcine models.
RESULTS: Assessment of differences in stain impregnation between the upper, middle, and lower abdomen did not reveal significant differences (p = 0.42). The median sum scores were 1 for the upper abdomen and 3 for the middle and lower abdomen.
CONCLUSIONS: Aerosolization does not reach all regions of the abdomen homogeneously. However, adequate exposure of the upper abdomen, mid-abdomen, and lower abdomen to chemotherapeutic agents can be achieved with PIPAC.

Entities:  

Keywords:  Aerosol; Innovation; Medical device; Peritoneal carcinomatosis; Pressure; Pressurized intraperitoneal aerosol chemotherapy (PIPAC)

Mesh:

Substances:

Year:  2019        PMID: 31372889     DOI: 10.1007/s00464-019-07043-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  14 in total

1.  Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator.

Authors:  M A Reymond; B Hu; A Garcia; T Reck; F Köckerling; J Hess; P Morel
Journal:  Surg Endosc       Date:  2000-01       Impact factor: 4.584

Review 2.  Air and soul: the science and application of aerosol therapy.

Authors:  Bruce K Rubin
Journal:  Respir Care       Date:  2010-07       Impact factor: 2.258

3.  Description of a novel approach for intraperitoneal drug delivery and the related device.

Authors:  Wiebke Solaß; Alexander Hetzel; Giorgi Nadiradze; Emil Sagynaliev; Marc A Reymond
Journal:  Surg Endosc       Date:  2012-05-12       Impact factor: 4.584

4.  Implantation Peritoneal Carcinomatosis of Ovarian Origin.

Authors:  J A Sampson
Journal:  Am J Pathol       Date:  1931-09       Impact factor: 4.307

5.  Technical description of the microinjection pump (MIP®) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC).

Authors:  Daniel Göhler; Veria Khosrawipour; Tanja Khosrawipour; David Diaz-Carballo; Thomas Albert Falkenstein; Jürgen Zieren; Michael Stintz; Urs Giger-Pabst
Journal:  Surg Endosc       Date:  2016-09-08       Impact factor: 4.584

6.  Scintigraphic peritoneography reveals a non-uniform 99mTc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model.

Authors:  Alexander Bellendorf; Veria Khosrawipour; Tanja Khosrawipour; Simon Siebigteroth; Joseph Cohnen; David Diaz-Carballo; Andreas Bockisch; Jürgen Zieren; Urs Giger-Pabst
Journal:  Surg Endosc       Date:  2017-06-22       Impact factor: 4.584

Review 7.  Intraperitoneal antineoplastic drug delivery: rationale and results.

Authors:  Maurie Markman
Journal:  Lancet Oncol       Date:  2003-05       Impact factor: 41.316

8.  Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.

Authors:  C Demtröder; W Solass; J Zieren; D Strumberg; U Giger-Pabst; M-A Reymond
Journal:  Colorectal Dis       Date:  2016-04       Impact factor: 3.788

9.  Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study.

Authors:  Clemens B Tempfer; Günther A Rezniczek; Paula Ende; Wiebke Solass; Marc-André Reymond
Journal:  Anticancer Res       Date:  2015-12       Impact factor: 2.480

10.  Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).

Authors:  Veria Khosrawipour; Tanja Khosrawipour; David Diaz-Carballo; Eckart Förster; Jürgen Zieren; Urs Giger-Pabst
Journal:  Ann Surg Oncol       Date:  2015-11-09       Impact factor: 5.344

View more
  1 in total

Review 1.  Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).

Authors:  Giorgi Nadiradze; Philipp Horvath; Yaroslav Sautkin; Rami Archid; Frank-Jürgen Weinreich; Alfred Königsrainer; Marc A Reymond
Journal:  Cancers (Basel)       Date:  2019-12-20       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.